Peregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing Facility
March 07, 2016 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
Sonoco Products Company Logo
Sonoco ThermoSafe Launches Reusable Container for Blood Transport and Storage
June 24, 2015 07:30 ET | Sonoco Products Company
ARLINGTON HEIGHTS, Ill., June 24, 2015 (GLOBE NEWSWIRE) -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and a leading supplier of temperature assurance packaging, has launched a revolutionary...
Patient Safeguards Needed for Biosimilar Development
August 08, 2014 17:46 ET | RetireSafe
MISSION, KS--(Marketwired - Aug 8, 2014) - (Family Features) Thanks to a provision in the Patient Protection and Affordable Care Act, efforts are underway to streamline licensing for medications...
Noble Expands Into Global Biologics Market With Multisensory Device Training
August 07, 2013 09:15 ET | Noble
ORLANDO, FL--(Marketwired - Aug 7, 2013) -  Noble®, the leader in the design and manufacturing of training devices, is expanding its services to the global biologics market, offering...
Fourth-Generation Biologics Set to Drive Over $120 Billion Market
July 09, 2013 07:30 ET | Lux Research
BOSTON, MA--(Marketwired - Jul 9, 2013) - Fourth-generation biologics, with improved delivery and pharmacokinetics, will continue to drive an overall biologics industry that is already worth over...
Battelle Wins $102M NIAID Biodefense Research Contract
July 18, 2012 10:30 ET | Battelle
COLUMBUS, OH--(Marketwire - Jul 18, 2012) - Battelle has won a single-source award from the U.S. Department of Health and Human Services' National Institutes of Health for evaluation and testing...
Biologics Dominate the Autoimmune Market but Small Molecules Still Have Some Fight Left, Says Cutting Edge Information
June 30, 2009 09:51 ET | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - June 30, 2009) - Biological drugs are the big winners in the market for autoimmune disorders. According to "Autoimmune Market Forecast to 2014," the latest...